login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
SAREPTA THERAPEUTICS INC (SRPT) Stock News
USA
- NASDAQ:SRPT -
US8036071004
-
Common Stock
18.81
USD
+0.99 (+5.56%)
Last: 11/14/2025, 8:28:03 PM
18.76
USD
-0.05 (-0.27%)
After Hours:
11/14/2025, 8:28:03 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
SRPT Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: Chartmill
- Mentions:
TGE
HTZ
DENN
KFRC
...
Which stocks are experiencing notable movement on Tuesday?
11 days ago - By: Chartmill
- Mentions:
TGE
HTZ
DENN
KFRC
...
Tuesday's session: top gainers and losers
11 hours ago - By: Benzinga
Sarepta Shares Jump After FDA Approves Updated Elevidys Label
14 hours ago - By: Sarepta Therapeutics, Inc.
Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information
14 hours ago - By: Bloomberg
Sarepta’s Elevidys to Remain on Market With New FDA Warning
4 days ago - By: Benzinga
- Mentions:
TEVA
EW
LLY
MDT
...
10 Health Care Stocks With Whale Alerts In Today's Session
11 days ago - By: Zacks Investment Research
SRPT Q3 Earnings Miss Estimates, Stock Dips on DMD Study Failure
11 days ago - By: Chartmill
- Mentions:
TGE
PAY
FORD
HTZ
...
These stocks are gapping in today's session
11 days ago - By: Zacks Investment Research
Sarepta Therapeutics (SRPT) Reports Q3 Earnings: What Key Metrics Have to Say
11 days ago - By: Chartmill
- Mentions:
CYD
HTZ
DENN
NSP
...
Tuesday's pre-market session: top gainers and losers
11 days ago - By: Stocktwits
- Mentions:
SPY
DIA
PLTR
TSLA
...
Dow Futures Edge Lower On Pullback Fears: PLTR, SRPT, TSLA, AMD Among Stocks To Watch
11 days ago - By: Stocktwits
Sarepta Therapeutics Stock Crashes After-Hours On DMD Trial Failure, Q3 Print — Retail Still Sees Long-Term Comeback
11 days ago - By: Zacks Investment Research
- Mentions:
AGEN
Sarepta Therapeutics (SRPT) Reports Q3 Loss, Beats Revenue Estimates
11 days ago - By: Chartmill
- Mentions:
OC
SANM
NSP
FGL
...
These stocks are moving in today's after hours session
12 days ago - By: Bloomberg
Sarepta Says Older Muscle Disease Drugs Failed Confirmatory Trial
12 days ago - By: Investor's Business Daily
Sarepta Crashes After Two Muscular Dystrophy Drugs Fail Confirmatory Tests
12 days ago - By: Sarepta Therapeutics, Inc.
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
19 days ago - By: Sarepta Therapeutics, Inc.
Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results
23 days ago - By: Stocktwits
- Mentions:
BLSH
DASH
FLY
IREN
...
Tradr Debuts Leveraged ETFs on BLSH, DASH, FLY, IREN, NEM, OPEN, QS, SRPT & WULF
a month ago - By: Stocktwits
Why Sarepta Therapeutics Stock Is Rising Nearly 5% Premarket
a month ago - By: Sarepta Therapeutics, Inc.
Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2025 World Muscle Society Congress
Please enable JavaScript to continue using this application.